Results 211 to 220 of about 29,623 (261)

An enzyme immunoassay for the anabolic agent zeranol

Food Additives and Contaminants, 1989
A competitive enzyme immunoassay (EIA) for the detection and quantitation of zeranol has been developed. The assay involves the use of excess second antibody adsorbed onto the walls of a microtitration plate well. Enzyme-labelled zeranol, prepared by the N-succinimidyl ester method, and standard or samples are added to the wells followed by zeranol ...
P J, Patel, S N, Dixon
openaire   +2 more sources

Anabolic Agents for Osteoporosis

Treatments in Endocrinology, 2006
Antiresorptive agents for osteoporosis are a cornerstone of therapy, but anabolic drugs have recently widened our therapeutic options. By directly stimulating bone formation, anabolic agents reduce fracture incidence by improving other bone qualities in addition to increasing bone mass. Teriparatide (human parathyroid hormone[1-34]) has clearly emerged
Monica, Girotra, Mishaela R, Rubin, John P, Bilezikian   +2 more
openaire   +2 more sources

Nutrition and anabolic agents in burned patients

Burns, 2003
Much of the morbidity and mortality of severely burned patients is connected with hypermetabolism and catabolism with its accompanying impairment of wound healing and increased infection risks. In order to prevent the erosion of body mass, nutritional support and other strategies to prevent catabolism have become a major focus in the care of severely ...
Harald, Andel, Lars Peter, Kamolz, Klaus, Hörauf, Michael, Zimpfer   +3 more
openaire   +2 more sources

Anabolic agents for treating postmenopausal osteoporosis

Joint Bone Spine, 2001
The main efficacy criterion for drugs against osteoporosis is protection against fractures. Many resorption-inhibiting agents meet this criterion, including estrogens, alendronate, risedronate, raloxifene, calcitonin, and calcium-vitamin D supplements).
openaire   +2 more sources

Bone Anabolic Agents

2003
Bone remodeling is a complex but coupled process in which old bone is resorbed, followed by the formation of new bone. Ten percent of the human skeleton is remodeled per year. Osteoporosis is a disorder of bone remodeling characterized by uncoupling of resorption from formation. The net result is a loss of bone mass.
openaire   +1 more source

The Absorption, Distribution and Excretion of Anabolic Agents

Journal of Animal Science, 1983
The metabolic fate of the anabolic agents, diethylstilbestrol, hexestrol, trenbolone acetate, zeranol and the endogenous steroids are discussed under the headings absorption, distribution and excretion. There is an optimum concentration of anabolic agent in the systemic circulation that results in a maximum increase in growth rate of farm animals. This
openaire   +2 more sources

Anabolic Agents for Osteoporosis

Abstract The international VERO Trial addressed (1) whether teriparatide offers better fracture protection than risedronate, (2) which patients benefit from this treatment, and (3) the time pattern of the FRAX-defined major osteoporotic fracture (MOF) efficacy.
openaire   +1 more source

Latest on Anabolic Agents for Osteoporosis Treatment

Endocrinology and Metabolism Clinics of North America
In the last decades, novel therapeutics with anabolic bone properties have been developed and are currently used in the management of osteoporosis particularly in patients with high-risk of fragility fractures. These drugs include PTH-Related Analogues, teriparatide and abaloparatide, and the anti-sclerostin agent romosozumab, this latter drug ...
di Filippo L., Rosen C. J.
openaire   +3 more sources

Methandrostenolone, an Oral Anabolic Agent

Southern Medical Journal, 1964
E C, JUNGCK, R B, GREENBLATT
openaire   +2 more sources

Anabolic Agents for Postmenopausal Osteoporosis: How Do You Choose?

Current Osteoporosis Reports, 2021
Felicia Cosman, David W Dempster, Cosman Felicia   +2 more
exaly